ARCHIVE

• FJPWA Withholds Conclusion on Cooperation in Preliminary Drug Price Survey
  November 4, 2002

• EU Presents Proposals for Regulatory Reform in Japan
  November 4, 2002

• Price Settlement Rate 53.5% at the End of September: VITAL-NET
  November 4, 2002

• REGULATORY NEWS IN BRIEF
  November 4, 2002

• Bio Drugs to Account for 30% of All Drugs in 2010: Mr Nagayama at Medical Forum
  November 4, 2002

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  November 4, 2002

• Kuraya Sanseido to Achieve 2% Operating Profit Rate by Further Cutting Costs
  November 4, 2002

• Takeda Develops Simulation Software to Predict Prognosis of Diabetic Complications
  November 4, 2002

• Yoshitomi to Further Specialize in Psychiatric Field
  November 4, 2002

• Nihon Schering Introduces HTRF Technology for HTS
  November 4, 2002

• IMS Japan to Communicate Closely with Wholesalers to Dispel Misunderstanding
  November 4, 2002

• JCQHC to Start Publishing Therapeutic GLs from Next Year
  November 4, 2002

• Drug Market to Expand to \5,965 Bil. in FY2002: Analyst
  November 4, 2002

• PRESS SEMINAR
  November 4, 2002

• Review Fees to Be Hiked in April 2004
  October 28, 2002

• DIAGNOSTIC NEWS IN BRIEF
  October 28, 2002

• Council Recommends Strategic Approaches toward IP
  October 28, 2002

• WORLD NEWS IN BRIEF
  October 28, 2002

• 3 Active Ingredients Including Flunase Nasal Solution Approved
  October 28, 2002

• Sankyo Acquires Cider Sante's Subsidiary of France
  October 28, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 642
• 643
• 644
• 645
• 646
• 647
• 648
• 649
• 650
• …
• Next ›
• 最終 »